This paper uses national and sub-national medicine outlet surveys conducted in eight study countries (Benin, Kinshasa and Kantanga [Democratic Republic of the Congo, DRC], Kenya, Madagascar, Nigeria, Tanzania, Uganda and Zambia) between 2009 and 2015 to describe the non quality-assured ACT (QAACT) market and to document trends in availability and distribution of non-QAACT in the public and private sector.
Measuring the strength of programme implementation and assessing its association with outcomes is a promising approach to strengthen pragmatic impact evaluation, both to assess impact and to identify which aspects of a programme need to be strengthened.
This study used a novel customised electronic monitoring device—termed smart blister packs—to examine the validity of self-reported adherence to artemether-lumefantrine (AL) in southern Tanzania. Smart blister packs resulted in lower estimates of timely completion of AL and may be less prone to recall and social desirability bias.
A study using a decision tree model and probabilistic sensitivity analysis to estimate the relative cost-effectiveness of RDTs, presumptive treatment and field standard microscopy in different epidemiological settings of sub-Saharan Africa where Plasmodium falciparum predominates.